BPL1 is a probiotic targeting metabolic health through body mass index (BMI) reduction with an impact on waist circumference and abdominal fat. BPL1 is a unique strain, as it’s available as a live probiotic and also as a heat-treated postbiotic that retains functional properties for waist circumference reduction and impacting abdominal fat.
According to ADM, it is the only probiotic in the market targeting weight management that also works as a postbiotic (i.e., when heat-treated), allowing for potential application across a wide variety of food and beverage products, from sports drinks and bars to dairy products, including ice cream. This formulation flexibility capability is critical in making probiotics more easily accessible to the masses and giving functional health benefits to foods and products that are already being enjoyed by millions of people regularly.
“We’re very pleased to be recognized by the BIG Innovation Awards for our continued advancements in the field of microbiome science,” said Ian Pinner, chief strategy and innovation officer, and president of ADM’s Health & Wellness division. “Today’s consumers face unprecedented health and wellness challenges, and we are committed to delivering leading-edge microbiome research and innovation to help our customers provide science-backed metabolic health solutions in a wide range of convenient, consumer-friendly applications.”
Organizations from across the globe submitted their recent innovations for consideration in the BIG Innovation Awards. Nominations were then judged by a select group of business leaders and executives who volunteer their time and expertise to score submissions.
